Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Strategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
A fresh economic study from Anthropic introduces a chart mapping automation risk by occupation. The takeaway is nuanc...
Horizon Technology Finance slashes its monthly distribution to $0.06 per share, triggering a sharp stock selloff as f...
As inflation runs hot and rate prospects swing, retail investors nod to inflation-defensive plays. Smithfield Foods a...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...
Oil markets stabilize as July opens, setting up a three-stock energy play. Exxon, Chevron, and ConocoPhillips offer d...
Is UPS stock a long-term winner? This guide breaks down the turnaround story, real numbers, and a clear plan for eval...
Strategy faces a tough trade-off: use cash to back STRC dividends and buy Bitcoin, or raise fresh capital that dilute...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
Nvidia is set to outline how it will deploy its cash as AI demand drives growth. The company still pays a token divid...
Strategy reports a second BTC sale in six weeks, expanding liquidity and reshaping long-term exposure to crypto.